# FDA Inspection 1046160 - Lance Ellis - February 27, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/lance-ellis/392da94a-1cdc-4ad1-9400-6115f116048b
Source feed: FDA_Inspections

> FDA Inspection 1046160 for Lance Ellis on February 27, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046160
- Company Name: Lance Ellis
- Inspection Date: 2018-02-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269846 - 2025-05-05](https://www.globalkeysolutions.net/records/fda_inspections/lance-ellis/be193bf3-2d60-4261-baea-ee674e024445)
- [FDA Inspection 1269846 - 2025-05-05](https://www.globalkeysolutions.net/records/fda_inspections/lance-ellis/c787e2ff-f781-4b7c-ae69-f586ce7bd6c5)

Company: https://www.globalkeysolutions.net/companies/lance-ellis/48fc6daf-1e12-4e2d-91fa-336ffe86a941

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d